Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · USD

$6.13

+0.15 (+2.5%)· Recorded snapshot

Market cap	796.8M
Revenue (ttm)	206.7M
Net income (ttm)	-80.6M
EPS (ttm)	-$0.63
Shares out	130M
Volume	1,397,487
Beta	1.16

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 206.7M
Net income (ttm): -80.6M
EPS (ttm): -$0.63
Market cap: 796.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-23

P25 n/aP50 n/aP75 n/a

ROIC-52.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CTKB indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001831915
Company name	Cytek Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	23285D109
Earnings date	2026-11-04
Earnings time	amc
Employees	682
Employees change	-6
Employees growth	-0.87%
Enterprise value	$561.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1990
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2021-07-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US23285D1090
Last 10-K release date	2026-02-26
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$796.8M
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$6.13
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	CTKB
U.S. state	California
Website	https://cytekbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.26%
EV/Sales	2.7x
FCF / EV yield	-2.16%
FCF yield	-1.52%
Forward EV/Sales	2.58x
Forward P/S	3.66x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	2.41x
P/S ratio	3.84x
Price / tangible book value	2.73x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-22.95%
EBITDA margin	-19.24%
Gross margin	51.87%
Operating margin	-22.95%
Pretax margin	-19.75%
Profit margin	-38.98%
Profit per employee	$-118,150
Revenue per employee	$303,092
ROA	-6.31%
ROA (5Y)	-1.96%
ROCE	-13.09%
ROE	-23.04%
ROE (5Y)	-4.18%
ROIC	-52.92%
ROIC (5Y)	-11.41%
SBC / revenue	10.34%
Tax / revenue	19.24%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	0.51%
Gross profit growth (Q)	7.01%
Gross profit growth 3Y	0.56%
Gross profit growth 5Y	9.12%
Net income growth years	0
OCF growth (Q)	1,165.74%
Revenue growth	5.45%
Revenue growth (Q)	5.57%
Revenue growth (QoQ)	9.07%
Revenue growth 3Y	5.59%
Revenue growth 5Y	13.37%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6M
Depreciation and amortization	$7.7M
EBIT	$-47.4M
EBITDA	$-39.8M
EPS	$-0.63
FCF per share	$-0.09
Financing cash flow	$3.9M
Free cash flow	$-12.1M
Free cash flow minus SBC	$-33.4M
Gross profit	$107.2M
Income taxes	$39.8M
Investing cash flow	$-3M
Net borrowing	$3M
Net cash flow	$-1.6M
Net income	$-80.6M
Operating cash flow minus SBC	$-27.4M
Operating income	$-47.4M
Revenue	$206.7M
Stock-based compensation	$21.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.15
Book value per share	$2.48
Debt / equity	0.08
Goodwill	$16.7M
Interest coverage	-152.08
Long-term assets	$69M
Long-term liabilities	$40.6M
Net cash (debt)	$235.5M
Net cash / market cap	29.66%
Net cash growth	-1.17%
Net debt / equity	-0.73
Piotroski F-Score	3
Property, plant and equipment	$31.8M
Shareholders' equity	$322M
Tangible book value	$290.4M
Tangible book value per share	$2.23
Total assets	$446.9M
Total cash	$262M
Total debt	$26.5M
Total liabilities	$125M
WACC	10.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	$377.9M
Current liabilities	$84.3M
Current ratio	4.48
Inventory turnover	1.93
Net working capital	$44.3M
Quick ratio	3.71
Working capital	$293.6M
Working capital turnover	0.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.28%
Dividend yield	0%
Shareholder yield	0.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.65
1D price change	2.51%
1M price change	7.43%
1M total return	7.43%
1W price change	13.67%
1W total return	13.67%
1Y price change	46.27%
1Y return CAGR	46.3%
1Y total return	46.27%
20-day SMA	$5.55
200-day SMA	$4.65
3M price change	37.64%
3M total return	37.64%
3Y price change	40.19%
3Y return CAGR	11.92%
3Y total return	40.19%
50-day SMA	$5.22
50-day SMA vs 200-day SMA	50over200
52-week high	$6.32
52-week high date	2026-10-28
52-week low	$3.31
52-week low date	2026-05-14
5Y price change	-73.95%
5Y return CAGR	-23.59%
5Y total return	-73.95%
6M price change	36.1%
6M total return	36.1%
All-time high	$28.70
All-time high date	2021-09-15
All-time low	$2.37
All-time low date	2025-05-23
Average true range (ATR)	$0.28
Average volume	1.3M
Beta (1Y)	-0.18
Beta (2Y)	1.1
Beta (5Y)	1.16
Change from 52-week high	-3.01%
Change from 52-week low	85.2%
Change from all-time high	-78.85%
Change from all-time low	156.12%
Change from open	1.32%
Day's gap	1.17%
Dollar volume	$8.6M
High price	$6.31
Low price	$6.00
Monthly RSI	54.13
Open price	$6.05
Position in 52-week range	41.94%
Premarket change	0.17%
Premarket close	$5.98
Premarket price	$5.99
Premarket volume	267
Previous close	$5.98
Price vs 150-day SMA	30.68%
Price vs 20-day SMA	9.33%
Price vs 200-day SMA	30.62%
Price vs 50-day SMA	16.4%
Relative volume	1.04
Return from IPO open	-69.6%
Return from IPO price	-64.06%
RSI	68.35
Sharpe ratio	0.89
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	-0.19
Sortino ratio	1.48
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	-0.18
Volume	1.4M
Weekly RSI	65.42
YTD price change	20.2%
YTD total return	20.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	102.9M
Float percentage	79.2%
Shares change (QoQ)	0.59%
Shares change (YoY)	-0.28%
Shares held by insiders	8.48%
Shares held by institutions	50.98%
Shares outstanding	130M
Short % of float	4.28%
Short % of shares	3.39%
Short ratio	4 days

Deeper analysis on CTKB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CTKB report

Is a complete CTKB research report available?

No complete published report is available for Cytek Biosciences, Inc. (CTKB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cytek Biosciences, Inc. (CTKB)

Price

Financial snapshot

Fair-value bridge

Latest news · CTKB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CTKB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CTKB

Frequently asked questions